PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 100 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $302,000 | -32.0% | 79,524 | -8.6% | 0.00% | – |
| Q4 2019 | $444,000 | -68.1% | 87,019 | -68.4% | 0.00% | -100.0% |
| Q3 2019 | $1,393,000 | +20.1% | 275,523 | +46.6% | 0.00% | 0.0% |
| Q2 2019 | $1,160,000 | +67.1% | 187,994 | +25.8% | 0.00% | – |
| Q1 2019 | $694,000 | -73.4% | 149,382 | -76.0% | 0.00% | -100.0% |
| Q4 2018 | $2,611,000 | +152.8% | 621,683 | +277.7% | 0.00% | +100.0% |
| Q3 2018 | $1,033,000 | -33.9% | 164,614 | -15.3% | 0.00% | 0.0% |
| Q2 2018 | $1,562,000 | +4.1% | 194,282 | -3.4% | 0.00% | 0.0% |
| Q1 2018 | $1,501,000 | +14.2% | 201,197 | -8.8% | 0.00% | 0.0% |
| Q4 2017 | $1,314,000 | -11.6% | 220,669 | +9.3% | 0.00% | 0.0% |
| Q3 2017 | $1,486,000 | -1.2% | 201,903 | -8.8% | 0.00% | 0.0% |
| Q2 2017 | $1,504,000 | +35.1% | 221,486 | +87.8% | 0.00% | 0.0% |
| Q1 2017 | $1,113,000 | -30.1% | 117,968 | -36.0% | 0.00% | 0.0% |
| Q4 2016 | $1,593,000 | +1542.3% | 184,456 | +1102.8% | 0.00% | – |
| Q3 2016 | $97,000 | +203.1% | 15,335 | +100.2% | 0.00% | – |
| Q2 2016 | $32,000 | -87.5% | 7,658 | -87.0% | 0.00% | – |
| Q1 2016 | $257,000 | +594.6% | 58,888 | +866.0% | 0.00% | – |
| Q4 2015 | $37,000 | -92.1% | 6,096 | -92.6% | 0.00% | – |
| Q3 2015 | $470,000 | +203.2% | 82,166 | +296.5% | 0.00% | – |
| Q2 2015 | $155,000 | +63.2% | 20,724 | +31.0% | 0.00% | – |
| Q1 2015 | $95,000 | -54.5% | 15,816 | -42.6% | 0.00% | – |
| Q4 2014 | $209,000 | +1392.9% | 27,578 | +976.4% | 0.00% | – |
| Q3 2014 | $14,000 | +133.3% | 2,562 | +86.3% | 0.00% | – |
| Q2 2014 | $6,000 | -90.6% | 1,375 | -91.3% | 0.00% | – |
| Q1 2014 | $64,000 | -49.6% | 15,747 | -34.0% | 0.00% | – |
| Q4 2013 | $127,000 | +81.4% | 23,845 | +72.1% | 0.00% | – |
| Q3 2013 | $70,000 | +250.0% | 13,853 | +212.7% | 0.00% | – |
| Q2 2013 | $20,000 | – | 4,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|